AstraZeneca Said to Have Explored Bristol Myers Merger

AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.